$CPXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Celator Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Celator Pharmaceuticals Inc. Get notifications about new insider transactions in Celator Pharmaceuticals Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | D | 5.21 | 12,832 | 66,884 | 0 | |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | D | 5.21 | 11,027 | 57,476 | 0 | |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | D | 2.60 | 14,000 | 36,400 | 0 | |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | D | 2.80 | 14,000 | 39,200 | 0 | |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | D | 3.12 | 28,000 | 87,248 | 0 | |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | X | 3.58 | 35,737 | 127,938 | 0 | |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | X | 3.58 | 30,708 | 109,935 | 0 | |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | X | 5.21 | 19,076 | 99,430 | 0 | |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | X | 5.21 | 16,391 | 85,435 | 0 | |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Sell | U | 30.25 | 637,962 | 19,298,351 | 0 | 638 K to 0 (-100.00 %) |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Sell | U | 30.25 | 1,327,888 | 40,168,612 | 0 | 1.3 M to 0 (-100.00 %) |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Buy | X | 0.00 | 47,265 | 0 | 637,962 | 590.7 K to 638 K (+8.00 %) |
Jul 13 2016 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Buy | X | 0.00 | 40,614 | 0 | 1,327,888 | 1.3 M to 1.3 M (+3.16 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Option Exercise | J | 3.58 | 889,403 | 3,184,063 | 0 | ||
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Option Exercise | J | 5.21 | 34,647 | 180,591 | 0 | ||
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Sell | U | 30.25 | 564,222 | 17,067,716 | 0 | 564.2 K to 0 (-100.00 %) | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Sell | U | 30.25 | 1,591,750 | 48,150,438 | 0 | 1.6 M to 0 (-100.00 %) | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | U | 3.58 | 314,611 | 1,126,307 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | D | 3.58 | 358 | 1,282 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | D | 3.12 | 28,000 | 87,248 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | D | 2.80 | 14,000 | 39,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | D | 2.60 | 14,000 | 36,400 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Sell | U | 30.25 | 1,039,109 | 31,433,047 | 0 | 1 M to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Sell | D | 30.25 | 6,277 | 189,879 | 0 | 6.3 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Option Exercise | J | 3.58 | 44,740 | 160,169 | 0 | ||
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Option Exercise | J | 3.58 | 314,611 | 1,126,307 | 0 | ||
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Sell | U | 30.25 | 143,986 | 4,355,577 | 0 | 144 K to 0 (-100.00 %) | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Sell | U | 30.25 | 1,039,109 | 31,433,047 | 0 | 1 M to 0 (-100.00 %) | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 2.60 | 14,000 | 36,400 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 2.80 | 14,000 | 39,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 3.12 | 28,000 | 87,248 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 3.58 | 85,777 | 307,082 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 5.21 | 32,091 | 167,268 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 5.21 | 44,495 | 231,921 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 5,867 | 177,477 | 0 | 5.9 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 16,733 | 506,173 | 0 | 16.7 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 2,378,924 | 71,962,451 | 0 | 2.4 M to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 2.60 | 14,000 | 36,400 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 2.80 | 14,000 | 39,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 3.12 | 28,000 | 87,248 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 3.58 | 85,777 | 307,082 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 5.21 | 32,091 | 167,268 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 5.21 | 44,495 | 231,921 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 5,867 | 177,477 | 0 | 5.9 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 16,733 | 506,173 | 0 | 16.7 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 2,378,924 | 71,962,451 | 0 | 2.4 M to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 2.60 | 14,000 | 36,400 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 2.80 | 14,000 | 39,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 3.12 | 28,000 | 87,248 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 3.58 | 85,777 | 307,082 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 5.21 | 32,091 | 167,268 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 5.21 | 44,495 | 231,921 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 5,867 | 177,477 | 0 | 5.9 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 16,733 | 506,173 | 0 | 16.7 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 2,378,924 | 71,962,451 | 0 | 2.4 M to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 2.60 | 14,000 | 36,400 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 2.80 | 14,000 | 39,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 3.12 | 28,000 | 87,248 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 3.58 | 85,777 | 307,082 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 5.21 | 32,091 | 167,268 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | D | 5.21 | 44,495 | 231,921 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 5,867 | 177,477 | 0 | 5.9 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 16,733 | 506,173 | 0 | 16.7 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Sell | D | 30.25 | 2,378,924 | 71,962,451 | 0 | 2.4 M to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | VP and Chief Financ ... | Option Exercise | D | 1.32 | 137,500 | 181,500 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | VP and Chief Financ ... | Option Exercise | D | 2.79 | 55,000 | 153,450 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | VP and Chief Financ ... | Option Exercise | D | 3.22 | 50,000 | 161,000 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | VP and Chief Financ ... | Option Exercise | D | 3.12 | 181,113 | 564,348 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | VP and Chief Financ ... | Sell | D | 30.25 | 156,064 | 4,720,936 | 0 | 156.1 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | BIZZARI JEAN-PIERRE | Director | Option Exercise | D | 2.60 | 14,000 | 36,400 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | BIZZARI JEAN-PIERRE | Director | Option Exercise | D | 2.77 | 28,000 | 77,560 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Lobacki Joseph M | Director | Option Exercise | D | 2.60 | 14,000 | 36,400 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Lobacki Joseph M | Director | Option Exercise | D | 2.80 | 14,000 | 39,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Lobacki Joseph M | Director | Option Exercise | D | 3.47 | 28,000 | 97,160 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 1.32 | 118,835 | 156,862 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 1.32 | 295,000 | 389,400 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 2.79 | 175,000 | 488,250 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 3.22 | 157,000 | 505,540 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 3.12 | 333,724 | 1,039,884 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | D | 2.44 | 98,409 | 240,118 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Sell | D | 30.25 | 301,518 | 9,120,920 | 0 | 301.5 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | MOLLICA JOSEPH A | Director | Option Exercise | D | 2.60 | 14,000 | 36,400 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | MOLLICA JOSEPH A | Director | Option Exercise | D | 2.80 | 14,000 | 39,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | MOLLICA JOSEPH A | Director | Option Exercise | D | 3.12 | 28,000 | 87,248 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | MOLLICA JOSEPH A | Director | Option Exercise | D | 3.37 | 26,668 | 89,871 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Option Exercise | D | 1.32 | 35,676 | 47,092 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Option Exercise | D | 1.32 | 175,000 | 231,000 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Option Exercise | D | 2.79 | 80,000 | 223,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Option Exercise | D | 3.22 | 50,000 | 161,000 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Option Exercise | D | 3.12 | 200,000 | 623,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Option Exercise | D | 3.37 | 28,217 | 95,091 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Sell | D | 30.25 | 3,631 | 109,838 | 0 | 3.6 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Sell | D | 30.25 | 7,468 | 225,907 | 0 | 7.5 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Sell | D | 30.25 | 107,515 | 3,252,329 | 0 | 107.5 K to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Option Exercise | D | 1.32 | 17,457 | 23,043 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Option Exercise | D | 1.32 | 75,000 | 99,000 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Option Exercise | D | 2.18 | 500,000 | 1,090,000 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Option Exercise | D | 2.60 | 22,000 | 57,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Option Exercise | D | 2.65 | 20,600 | 54,590 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Option Exercise | D | 2.80 | 14,000 | 39,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Option Exercise | D | 3.12 | 28,000 | 87,248 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Sell | D | 30.25 | 20,000 | 605,000 | 0 | 20 K to 0 (-100.00 %) |
Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | M | 3.12 | 96,276 | 299,996 | 333,724 | |
Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | M | 2.44 | 117,064 | 285,636 | 98,409 | |
Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | M | 3.37 | 38,135 | 128,515 | 0 | |
Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Buy | M | 3.12 | 96,276 | 299,996 | 301,518 | 205.2 K to 301.5 K (+46.91 %) |
Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Buy | M | 2.44 | 117,064 | 285,636 | 205,242 | 88.2 K to 205.2 K (+132.76 %) |
Jul 07 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Buy | M | 3.37 | 38,135 | 128,515 | 88,178 | 50 K to 88.2 K (+76.20 %) |
Jul 07 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | VP and Chief Financ ... | Option Exercise | M | 3.12 | 71,887 | 224,000 | 181,113 | |
Jul 07 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | VP and Chief Financ ... | Buy | M | 3.12 | 71,887 | 224,000 | 156,064 | 84.2 K to 156.1 K (+85.40 %) |
Jul 01 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | VP and Chief Financ ... | Gift | G | 0.00 | 1,665 | 0 | 84,177 | 85.8 K to 84.2 K (-1.94 %) |
Jun 27 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | See Remarks | Option Exercise | M | 1.32 | 56,875 | 75,075 | 0 | |
Jun 27 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | See Remarks | Payment of Exercise | F | 30.15 | 2,491 | 75,104 | 85,842 | 88.3 K to 85.8 K (-2.82 %) |
Jun 27 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | See Remarks | Buy | M | 1.32 | 56,875 | 75,075 | 88,333 | 31.5 K to 88.3 K (+180.80 %) |
Jun 22 2016 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Gift | G | 0.00 | 1,926 | 0 | 1,591,750 | 1.6 M to 1.6 M (-0.12 %) | |
Jun 22 2016 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Gift | G | 0.00 | 564,222 | 0 | 564,222 | 0 to 564.2 K | |
Jun 22 2016 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Gift | G | 0.00 | 564,222 | 0 | 1,593,676 | 2.2 M to 1.6 M (-26.15 %) | |
Jun 22 2016 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Gift | G | 0.00 | 88,571 | 0 | 2,157,898 | 2.2 M to 2.2 M (-3.94 %) | |
Jun 22 2016 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Gift | G | 0.00 | 28,000 | 0 | 143,986 | 172 K to 144 K (-16.28 %) | |
Jun 22 2016 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Gift | G | 0.00 | 84,503 | 0 | 1,039,109 | 1.1 M to 1 M (-7.52 %) | |
Mar 17 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | President and Head ... | Option Exercise | M | 2.25 | 48,002 | 108,005 | 0 | |
Mar 17 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | President and Head ... | Payment of Exercise | F | 8.94 | 12,081 | 108,004 | 107,515 | 119.6 K to 107.5 K (-10.10 %) |
Mar 17 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | President and Head ... | Buy | M | 2.25 | 48,002 | 108,005 | 119,596 | 71.6 K to 119.6 K (+67.05 %) |
Jan 29 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | Vice President and ... | Option Exercise | A | 1.32 | 56,875 | 75,075 | 56,875 | |
Jan 29 2016 | CPXX | Celator Pharmaceut ... | Powell Fred M | Vice President and ... | Option Exercise | A | 1.32 | 137,500 | 181,500 | 137,500 | |
Jan 29 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | A | 1.32 | 118,835 | 156,862 | 118,835 | |
Jan 29 2016 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | A | 1.32 | 295,000 | 389,400 | 295,000 | |
Jan 29 2016 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Option Exercise | A | 1.32 | 17,457 | 23,043 | 17,457 | |
Jan 29 2016 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Option Exercise | A | 1.32 | 75,000 | 99,000 | 75,000 | |
Jan 29 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | President & Chief S ... | Option Exercise | A | 1.32 | 35,677 | 47,094 | 35,677 | |
Jan 29 2016 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | President & Chief S ... | Option Exercise | A | 1.32 | 175,000 | 231,000 | 175,000 | |
Dec 07 2015 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Buy | P | 1.87 | 5,000 | 9,325 | 6,277 | 1.3 K to 6.3 K (+391.54 %) |
Dec 04 2015 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Option Exercise | P | 3.58 | 38,805 | 138,922 | 889,403 | ||
Dec 04 2015 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Option Exercise | P | 5.21 | 34,647 | 180,591 | 34,647 | ||
Oct 07 2015 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Buy | P | 1.74 | 14,450 | 25,143 | 50,043 | 35.6 K to 50 K (+40.60 %) |
Oct 05 2015 | CPXX | Celator Pharmaceut ... | Powell Fred M | VP and Chief Financ ... | Buy | P | 1.78 | 13,700 | 24,386 | 31,458 | 17.8 K to 31.5 K (+77.15 %) |
Oct 02 2015 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Buy | P | 1.64 | 2,000 | 3,280 | 171,986 | 170 K to 172 K (+1.18 %) | |
Oct 02 2015 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Buy | P | 1.66 | 3,000 | 4,980 | 169,986 | 167 K to 170 K (+1.80 %) | |
Oct 02 2015 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Buy | P | 1.68 | 2,000 | 3,360 | 166,986 | 165 K to 167 K (+1.21 %) | |
Oct 02 2015 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Buy | P | 1.62 | 5,000 | 8,100 | 164,986 | 160 K to 165 K (+3.13 %) | |
Oct 02 2015 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Buy | P | 1.67 | 200 | 334 | 159,986 | 159.8 K to 160 K (+0.13 %) | |
Aug 24 2015 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Executive Chairman | Option Exercise | A | 2.18 | 500,000 | 1,090,000 | 500,000 | |
Jun 15 2015 | CPXX | Celator Pharmaceut ... | MOLLICA JOSEPH A | Director | Option Exercise | A | 2.60 | 14,000 | 36,400 | 14,000 | |
Jun 15 2015 | CPXX | Celator Pharmaceut ... | Lobacki Joseph M | Director | Option Exercise | A | 2.60 | 14,000 | 36,400 | 14,000 | |
Jun 15 2015 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 2.60 | 22,000 | 57,200 | 22,000 | |
Jun 15 2015 | CPXX | Celator Pharmaceut ... | BIZZARI JEAN-PIERRE | Director | Option Exercise | A | 2.60 | 14,000 | 36,400 | 14,000 | |
Jun 15 2015 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | A | 2.60 | 14,000 | 36,400 | 14,000 | |
Jun 15 2015 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | A | 2.60 | 14,000 | 36,400 | 14,000 | |
Jun 12 2015 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | A | 2.60 | 14,000 | 36,400 | 14,000 | |
May 28 2015 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Option Exercise | M | 2.25 | 55,000 | 123,750 | 7,829 |